POINT 1 Study

Free

0.3.26for iPhone, iPad

Parallel 6, Inc.

Developer

Jul 24, 2018

Update Date

Medical

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

POINT 1 Study Screenshots

iPad

iPhone

About POINT 1 Study

"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.

The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."

What's New in the Latest Version 0.3.26

Last updated on Jul 24, 2018

Old Versions

1. Removed bluetooth option for Glucometer reading transfer 2. Added logic into the app where if a Glucose reading of less than 70mg/dl (Hypoglycemic Event), it automatically redirects you to symptom reporting screens.

Version History

0.3.26

Sep 27, 2017

Feedback Report